Darrell Borger

Darrell Borger

Company: Takeda

Job title: Associate Director, Translational Oncology, ODDU

Bio:

Darrell Borger is Associate Director of the Translational Oncology program in Takeda’s Oncology Drug Development Unit and Head of the Integrated Translational Technologies Laboratory. During his 1.5 years at Takeda, he has been developing innovative approaches to identify changes in the activity of immune cells within intact tumor tissue in response to novel immune modulating therapies undergoing preclinical development. Darrell joined Takeda from Massachusetts General Hospital where he developed several clinical laboratories that implemented novel technologies that molecularly “fingerprinted” a cancer patient’s tumor and allowed clinicians to direct their patients to specific drugs that they were most likely to respond to. He received his PhD in Biomedical Sciences at the University of South Carolina, School of Medicine and completed his post-doctoral training at the Dana Farber Cancer Institute where he identified novel cancer pathways and mechanisms of resistance to cancer treatment.

Seminars:

4.45 | 1.45 Live Audience Q+A 4:45 pm

Read more

day: Day One

3.45 | 12.45 Immune Profiling to Guide the Development of Next- Generation Immunotherapies 3:45 pm

Read more

day: Day One

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.